The cholesterol problem, the egg and lipid metabolism in the laying hen

Effects of 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors on Cholesterol Metabolism in Laying Hens

This study aimed to investigate the effect of HMGCR inhibitors on egg yolk cholesterol content and its biological mechanisms. Four groups of 180-day-old laying hens (n = 8 cages/group, 6 laying hens/cage) were fed a corn/soybean-based diet (control) and the control diet supplemented with an HMGCR inhibitor at 60, 150, and 300 mg/kg for 4 weeks. The experimental results showed that adding HMGCR inhibitors of 150 mg/kg or more can significantly reduce the cholesterol content in the liver, yolk, serum, and pectoral muscles of laying hens. The RNA-seq results showed that compared with the control group, the addition of HMGCR inhibitors of 150 mg/kg or more to the diet significantly upregulated genes related to cholesterol synthesis in the liver, and the genes involved in steroid synthesis and metabolism, sterol synthesis and metabolism, and cholesterol synthesis and metabolism were all affected by the HMGCR inhibitors. In summary, adding HMGCR inhibitors of 150 mg/kg or more to the diet of hens can significantly reduce the cholesterol content in egg yolk. After the HMGCR inhibitors inhibited the activity of the liver HMGCR, they also altered the expression of genes related to cholesterol synthesis, bile acid synthesis, and cholesterol transport in the liver, and ultimately reduced cholesterol synthesis and cholesterol transport to the egg yolk.

Effect of dietary essential oil of oregano on performance parameters, gastrointestinal traits, blood lipid profile, and antioxidant capacity of laying hens during the pullet phase

Many benefits have been found in supplementing essential oils such as oregano oil (EOO) to poultry, including increased body weight gain, antioxidant activity, and better gastrointestinal morphology. However, few studies tested the influence of EOO supplementation on laying hens and reported conflicting results regarding its efficacy in improving their health and performance. Therefore, we aimed to explore the effects of dietary EOO on performance, gastrointestinal (GIT) traits, blood lipid, and antioxidant capacity in laying hens during the rearing phase. A total of 300-day-old Hy-line-Brown chicks were used, and treatment diets consisted of corn-soybean based either without (CON) or with EOO (Ecodiar®, 0.275 g/kg diet). Birds were randomized across treatments with five pens/treatment and 30-birds/pen. Pen weights and feed rejected were recorded every two weeks (1-17 weeks of age), to calculate daily feed intake (ADFI), body weight (BW), and daily weight gain (ADWG). At 11 and 14 weeks of age, blood samples were collected from 3 birds/pen and analyzed for blood lipids and antioxidant levels, and 5-birds/treatment were euthanized, and GIT traits were tested. Differences in measured parameters across weeks and between treatments were assessed using GLMM with Tukey’s Post hoc test applied to significant results in R 3.3.1 (α set at 0.05). Body weights at weeks 3, 11, 13, and 17 were significantly higher in the EOO group compared to the CON group (all P ≤ 0.05), ADWG was significantly higher in EOO birds compared to CON birds at 9 and 13 weeks old (all P ≤ 0.05), while no significant differences in ADFI were observed between treatments across weeks of the trials. At both 11 and 17 weeks old, triglyceride levels were significantly lower, while high-density-lipoprotein levels were higher in EOO (all P ≤ 0.05). Malondialdehyde levels were lower in the EOO group versus CON (p=0.01), while EOO birds had higher glutathione levels (p=0.01) than CON. Finally, at 12 weeks old, the weight of the entire GIT and empty gizzard were higher in the EOO group versus CON (all P ≤ 0.05), while liver and spleen weights were not significantly different between groups. In conclusion, dietary oregano supplementation exerted promoting effects on the performance of Hy-Line Brown pullets.

Dietary supplementation Eucommia ulmoides extract at high content served as a feed additive in the hens industry

Since numerous natural components in Eucommia ulmoides belong to phytoestrogen, its effect on hens production deserve more attention. To investigate the potential of E. ulmoides extract used as a feed additive, laying performance, egg quality, yolk cholesterol, yolk fatty acids, yolk fatty, yolk volatile components, albumen amino acids, plasma biochemical parameters, intestinal histology, and gut microbiota of hens (n = 120) were determined between basal diet (A) and dietary supplementation low (B), middle (C), and high (D) level E. ulmoides extract for 11 wk. When compared to A group, 2 percentage points elevation in laying rate was observed of D group. Significant up-regulation of immunoglobulin indexes and down-regulation of lipid related indexes in D group were also found if comparison with A group, suggesting that supplementation E. ulmoides extract at a relative high content benefited in immunity enhancing and blood-fat depressing. Meanwhile, obvious variation in albumen amino acids and yolk volatile compounds were inspected as dietary supplementation E. ulmoides extract, especially in D group, implied that the flavor of egg would change under high-level E. ulmoides extract treatment. Besides, villus height and villus height to crypt depth ratio of duodenum, jejunum, and ileum in D group were also significantly higher than that of in A group, indicating high-level E. ulmoides extract contributed to nutrient adsorption via intestinal histology changing. Moreover, the richness, diversity, and composition of gut microbiota in D group also significantly altered with a comparison of A group. These variation caused gut microbiota in D group major enriched in the KEGG pathway of insulin signing pathway, systemic lupus erythematosus, and bacterial invasion of epithelial cells, which were conducive to egg production elevation via facilitating nutrient adsorption, inflammation relieving, blood lipid amelioration, and insulin resistance alleviation. These results indicated that dietary supplementation E. ulmoides extract at high content could serve as a feed additive in the hens industry.

Effects of dietary supplementation with Ampelopsis grossedentata extract on production performance and body health of hens

To investigate the potential of Ampelopsis grossedentata extract used as a feed additive, laying performance, egg quality, yolk cholesterol, plasma biochemical parameters, intestinal histology, and gut microbiota of hens (n = 60) were determined between basal diet (CK) and dietary supplementation with A. grossedentata extract (RT) for 11 weeks. The laying rate in RT group was 6.3 percentage points higher than in CK group together with feed conversion rate decreasing. Significant upregulation of immunoglobulin indexes and downregulation of lipid-related indexes in RT group were also found in comparison with CK group, suggesting that dietary supplementation with A. grossedentata extract benefited in immunity enhancing and blood-fat depressing. Meanwhile, the villus height in duodenum and villus height to crypt depth ratio in duodenum and jejunum of RT group were significantly higher than that of CK group, indicating that dietary supplementation with A. grossedentata extract facilitated nutrient adsorption via intestinal histology changing. Moreover, the richness, diversity, and composition of gut microbiota in RT group significantly altered with a comparison of CK group, including beneficial bacterium and pathogenic bacterium, revealing that dietary supplementation with A. grossedentata extract could modify gut microbiota communities to affect intestinal adsorption and pathogen invasion. In addition, the lipid metabolism-related insulin signing pathway was significantly enriched by gut microbiota in RT group, which were conducive to egg production elevation via facilitating blood lipid amelioration and insulin resistance alleviation. These results provided a basis for A. grossedentata extract served as a feed additive in the hen industry.

Analysis of Serum Biochemical Indexes, Egg Quality, and Liver Transcriptome in Laying Hens Fed Diets Supplemented with Gynostemma pentaphyllum Powder

Gynostemma pentaphyllum (GP), known as “southern ginseng”, can reduce the blood pressure and blood lipid levels. In this study, 300 layer chicks of one day old were divided randomly into three groups (control group (base diet), high addition group (base diet with 1% GP), and low addition group (base diet with 0.5% GP)). After 29 weeks, the growth performance, egg quality, and serum index were determined. Additionally, liver mRNA was identified using RNA-seq to investigate the molecular mechanisms. The results indicated that the serum total cholesterol and triglycerides decreased significantly in the GP addition group. The addition of GP increased the egg weight, Haugh unit and redness (a*) of the egg yolk color, and reduced the yolk cholesterol concentration. Moreover, 95 differentially expressed genes (DEGs) were screened between the control and GP addition group. GO and the KEGG analysis showed that the PPAR pathway was significantly enriched. Five fatty acid metabolism-related genes (FABP3, CYP7A1, ANKRD22, SCD1, and PCK1) were validated by qRT-PCR analysis, which confirmed the tendency of the expression. These DEGs in the PPAR pathway may be the key factors of GP affecting fatty acid metabolism. These results may provide a theoretical basis for further research and new insights into GP as a feed additive.

Effects of Dietary Cottonseed Oil and Cottonseed Meal Supplementation on Liver Lipid Content, Fatty Acid Profile and Hepatic Function in Laying Hens

Antinutrients, such as cyclopropene fatty acids (CPFAs) and free gossypol (FG), present together in cottonseed have caused numerous adverse effects on liver health and egg quality of laying hens, which are both likely to be related to a disturbance in lipid metabolism. This experiment employed a 3 × 3 factorial arrangement using corn-soybean-meal-based diets supplemented with different levels of cottonseed oil (0%, 2%, or 4% CSO) containing CPFAs and cottonseed meal (0%, 6%, or 12% CSM) containing FG to elucidate the effects of them or their interaction on fatty acid profile, lipid content, and liver health of laying hens. An overall increase in fatty acid saturation and an overall significant decrease (p < 0.05) in monounsaturated fatty acids (MUFAs) were shown in the livers of hens fed diets with either 2% or 4% CSO. Meanwhile, the concentration of liver cholesterol, serum cholesterol, and serum LDL-c of hens fed a diet supplemented with a high level of CSO (4%) were noticeably increased (p < 0.05). Even though the supplementation of 4% CSO in diets aroused beneficial influences on liver function, a high level of CSO inclusion in laying hens' diets is not recommended due to its hypercholesterolemia effect. In conclusion, supplementation of CSO, which contains 0.20% CPFAs, was the primary cause of alteration in fatty acid composition and cholesterol content in hens, while no interaction between CSM and CSO nor CSM effect was found for lipid profile and liver health in laying hen.

Nutritional characteristics and quality of eggs from laying hens fed on a diet supplemented with chestnut tannin extract (Castanea sativa Miller)

The trial was performed with 80 laying hens belonging to two Tuscan autochthonous breeds: 40 birds of the Mugellese (MU) breed and 40 of the White Leghorn (WL) breed. The animals were allotted to 4 groups of individually caged 20 hens each: two groups were fed on a commercial diet and worked as the control groups (MUC and WLC); the other two groups received the same diet, integrated with 2 g of chestnut tannin (CT) extract per kg of diet (MUT and WLT). A sample of 70 eggs were randomly collected and analysed for cholesterol content, fatty acid (FA) profile, weight, thickness of shell and colour of yolk. Physical parameters, including yolk colour, and indices of egg quality were not affected by the treatments. The concentration of unsaturated FAs increased, whereas cholesterol was significantly decreased: -17% in WLT and -9% in MUT. Dietary supplementation with CT extract resulted in a modification of lipid composition, towards a more healthy quality of eggs.

Influence of source and percentage of fat added to diet on performance and fatty acid composition of egg yolks of two strains of laying hens

We conducted a trial to study the influence of strain of hen (white vs. brown) and source and percentage of added fat to diet on productive performance and fatty acid (FA) profile of the egg yolk. There were nine dietary treatments: a control diet without added fat and eight diets arranged as a 2 x 4 factorial (5 vs. 10% added tallow, olive, soy, or linseed oil). Each treatment was replicated five times, and the trial lasted 12 wk. White hens produced yolks with more saturated FA (P < 0.001) and less monounsaturated FA (P < 0.001) and polyunsaturated FA (P < 0.05) than brown hens. Fat supplementation improved egg mass output (P < 0.05) and feed efficiency of hens (P < 0.001). Linseed and soy oil diets produced greater egg mass than diets based on tallow or olive oil (59.6, 59.4, 57.9, and 57.1%, respectively; P < 0.001). The proportion of saturated FA in the yolk decreased as the percentage of added fat increased (36.5, 32.3, and 31.0% for diets containing 0, 5, and 10% added fat, respectively; P < 0.001). When the alpha-linolenic acid content of the diets increased from 0 to 0.8%, the arachidonic, docosapentanoic, and docosahexanoic acids in the egg yolk increased. Increases in the alpha-linolenic acid content of the diet over 2.3% did not further augment the concentration of docosapentanoic or docosahexanoic acid of the yolk and, in fact, decreased that of arachidonic acid. Only diets supplemented with linseed oil produced eggs with measurable amounts of eicosapentanoic acid. Diets supplemented with soy oil, with moderate levels of alpha-linolenic acid and high levels of linoleic acid, increased arachidonic and docosahexanoic acids in the egg yolk but not eicosapentanoic acid.

Select 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition

The inability to markedly attenuate cholesterol levels in chicken eggs has led to speculation that cholesterol is essential for yolk formation and that egg production would cease when yolk cholesterol deposition was inadequate for embryonic survival. However, this critical level hypothesis remains unproven. Here, we determine the relative responsiveness of laying hens to three select inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), the rate-limiting enzyme of cholesterol biosynthesis. A control diet, either alone or supplemented with one of two dietary levels (0.03 or 0.06%) of atorvastatin, lovastatin, or simvastatin, was fed to White Leghorn hens for 5 wk. Liver cholesterol concentrations (mg/g tissue) were decreased (P </= 0.05) by each HMGR inhibitor; however, total liver cholesterol (mg) did not differ among treatments. Microsomal hepatic HMGR activities were increased one- to twofold in all HMGR inhibitor-treated groups, while HMGR mRNA levels were unaffected. Diameters of plasma VLDL particles, the main cholesterol-carrying yolk precursor macromolecules, were reduced (P </= 0.05) only in hens fed 0.06% atorvastatin, and the particles contained 38% less total cholesterol (P </= 0.05) than controls. Plasma total cholesterol concentrations were lowered (P </= 0.05) by both doses of atorvastatin (-56, -63%) and simvastatin (-36,-45%). Egg cholesterol contents were maximally reduced by 46% (P </= 0.05), 7% (P > 0.05), and 22% (P </= 0.05) in hens fed the 0.06% level of atorvastatin, lovastatin, and simvastatin, respectively, while overall egg production [-19% (P </= 0.05), +4% (P > 0.05), and -3% (P > 0.05)], was much less affected. We concluded that cholesterol per se may not be an obligatory component for yolk formation in chickens and, as such, may be amenable to further pharmacological manipulation

Evaluation of two novel biochemicals on plasma and egg yolk lipid composition and laying hen performance

PD132301-2, an inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase (ACAT; EC 2.3.1.26), and 1-stearylboronic acid (SBA), a fatty acid analogue, were orally administered to White Leghorn hens in separate experiments to evaluate their effects on layer performance and plasma and egg yolk lipids. Five 60-wk-old hens each were fed either a corn-soybean meal basal layer ration, or the basal diet supplemented with .0121, .0363, or .1089% PD132301-2. In a second experiment, 12 37-wk-old hens each were fed either a basal layer ration, or the basal diet supplemented with .20 or .40% SBA. The duration of the experiments were 21 and 16 days, respectively. Neither compound significantly affected hen-day production, egg weight, yolk weight, BW gain, feed consumption, feed efficiency, plasma total cholesterol and triglyceride concentrations, or egg yolk cholesterol content. PD132301-2 had no effect on yolk fatty acid profiles, and C22:6n3 was the only fatty acid altered by SBA. Although 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors have been successful in reducing egg cholesterol, ACAT inhibitors and fatty acid analogues apparently hold little promise in this regard. The results of the present work also support the concept that, in order to pharmacologically alter the cholesterol content of eggs, direct inhibition of key enzymes in the cholesterol biosynthetic pathway is necessary.

Influence of probucol ((4,4'-isopropylidine dithio)-bis(2,6-di-t-butyl-phenol)) on egg yolk cholesterol content and performance of laying hens

Addition of the hypocholesteremic agent Probucol ((4,4'-isopropylidine dithio)-bis(2,6-di-t-butyl-phenol)) to the diet of laying hens at up to 1% significantly reduced egg yolk cholesterol content (mg/g yolk) without impairment of rate of egg production, egg weight, shell strength, albumen quality, or other production related parameters. Dietary concentration of .1% Probucol significantly reduced yolk cholesterol within 2 weeks after feeding. Higher concentrations did not further reduce yolk cholesterol. Probucol at .025% reduced egg yolk cholesterol within 4 weeks after feeding, but after 8 weeks of feeding, eggs from hens fed .025% Probucol did not differ significantly in yolk cholesterol from those fed the basal unsupplemented diet. This suggests possible adaptation in cholesterol synthesis by the laying hen.

The effect of feeding di-(2-ethylhexyl) phthalate and related compounds on lipids in the laying hen

Di-(2-ethylhexyl) phthalate (DEHP) and three structurally related side-chain analogs were fed to laying hens to determine relationships of structure to effects on lipid metabolism. Hubbard broiler breeder hens were fed either a standard laying mash control diet or the control diet containing DEHP, 2-ethylhexanol (2-EH), 2-ethylhexanal (2-EHALD), or 2-ethylhexanoic acid (2-EHA). Experimental treatments lowered feed consumption, body weight, and egg production. The DEHP and side-chain analog diets lowered plasma total lipids. DEHP, 2% 2-EH, and 1% 2-EHA diets lowered plasma free cholesterol. Liver weights were not significantly changed, but liver fat was reduced. Lipid classes were measured by quantitative thin layer chromatography densitometry. The decreases observed in plasma lipids occurred primarily in the triglyceride fraction. Liver lipid decreases occurred mainly in triglyceride and free fatty acid classes. Hen egg yolk percent fat, lipid classes, and free and total cholesterol were unaffected by any DEHP or side-chain analog diets. Plasma and liver hypolipidemic effects were observed with all of the oxidation state structural analogs of DEHP's side chain, but 2% 2-EH was the most effective treatment. These results suggest that the active portion of DEHP may be the metabolite, 2-EH, formed in vivo by hydrolysis of DEHP's ester bond.

Effect of cholesterol feeding on serum lipoproteins and atherosclerosis in atherosclerosis-susceptible and atherosclerosis-resistant Japanese quail

Male and female Japanese quail from two strains bred for differing susceptibility to induction of atherosclerosis by dietary cholesterol (RES = resistant, SUS = susceptible) were fed a control diet or control diet + .5% USP cholesterol. The diets were fed for 20 weeks beginning when the quail were 7 weeks old. Only quail fed cholesterol developed atherosclerosis. Atherosclerosis (incidence and severity) was higher in males than females and higher in SUS than RES. Cholesterol feeding increased aortic, liver, and serum cholesterol concentrations and liver total fat content. There were high positive correlations between serum cholesterol and liver cholesterol in all cholesterol-fed groups but not in control groups. Diet, sex, and strain differences in cholesterol distribution among the various serum lipoproteins and ratios of beta/alpha lipoproteins were observed. These differences are discussed in terms of their usefulness in predicting atherosclerosis in quail as compared with humans.

Effect of fiber on cholesterol metabolism in the Coturnix quail

This experiment involving 288 Coturnix quail was conducted to determine the effects of various fiber sources (alfalfa, wheat bran, dried brewer's grain, cellulose, and pectin) on serum, liver and egg yolk cholesterol, and egg production. The fiber sources were added at a rate to provide 6.25% fiber to a corn-soybean meal diet and fed for a 28-day experimental period. Serum, liver, and egg cholesterol levels were measured as pen composite samples at the end of the experimental period. No difference was exhibited in egg yolk cholesterol among any of the groups (P greater than .10). Liver and serum cholesterol levels were elevated in the birds fed the pectin and wheat brain diets as compared with that in birds fed the other fiber source; also, metabolizable energy intakes and eggs per hen day (EHD) were decreased for both groups. When data were adjusted for EHD by covariance analysis, the treatment differences no longer appeared (P greater than .05). These results indicate that 1) there is a basal quantity of cholesterol deposited in the egg on which fiber intake, energy consumed, or egg production have very little effect and that 2) there is an inverse relationship between serum and tissue cholesterol levels and the total quantity of cholesterol excreted via the egg.

Effects of branched and straight chain amines and azasteroids on blood and egg cholesterol of White Leghorn chickens

Six branched and straight chain secondary or tertiary amines with chain lengths of 12 to 18 carbons and two azasteroids, 25-aza-5 alpha-cholestane and 25-azacoprostane, were fed to mature White Leghorn hens, and their effectiveness was compared with 20,25-diazacholesterol dihydrochloride (SC-12937), an azasteroid known to lower egg cholesterol. Feed consumption, body weight, egg production, egg and plasma cholesterol and desmosterol, and plasma total lipid were measured. The 6 amines were fed at 200 ppm, and only the C12 branched chain amine N,N,3,711-pentamethyldodecanamine reduced plasma and egg cholesterol with a concomitant increase in desmosterol. After 4 weeks, plasma desmosterol was 0, 13, 60, and 75% of total sterol for control, 200 ppm C12 branched chain amine, 5 ppm diazacholesterol, and 5 ppm azacholestane, respectively. Egg production was severely reduced to 6 and 0% by feeding 5 ppm azacholestane for 2 and 4 weeks, respectively, and to 69 and 36% by feeding 5 ppm diazacholesterol. After 4 weeks egg cholesterol was 79 and 36% of the total sterol for the 200 ppm C12 branched chain amine and 5 ppm diazacholesterol, respectively. Concomitant increases in desmosterol accompanied all reductions in cholesterol. The depletion and repletion rates of egg cholesterol were measured in a subsequent experiment. After 2-1/2 weeks of feeding the test substances, egg cholesterol was reduced with concomitant increases in desmosterol. Egg cholesterol was 100, 71, and 50% of the total egg sterol for control, 200 ppm, and 400 ppm C12 branched chain amine, respectively: 58, 13, and 3% for .1, .5, and 1.0 ppm azacholestane; 28, 29, and 18% for 1, 2.5, and 5 ppm azacholesterol; and 23% for 1 ppm azacoprostane. The experimental diets were then withdrawn, and egg cholesterol repletion was studied biweekly. Egg cholesterol was repleted to 100% of the total sterol after withdrawal times of 2 weeks for C12 branched chain amine, 8 weeks for azacoprpostane, 14 to 16 weeks for diazacholesterol, 10 to 16 weeks for the lower levels of azacholestane, and longer than 16 weeks for 1 ppm azacholestane. The increase in desmosterol accompaning the demonstrated reduction in egg cholesterol, particularly with azasteroids, causes one to question the usefulness of this approach to lower cholesterol.

Yolk cholesterol in eggs from various avian species

Studies were conducted to establish the differences in yolk cholesterol concentrations in eggs from various avian species. Cholesterol was determined by a modification of the colorimetric procedure of Pearson et al. (1953). Species listed in increasing concentrations of cholesterol per gram of yolk, were guinea fowl, chicken, pheasant, quail, turkey, duck, goose, and dove with an overall range of 12.77 to 21.99 mg of cholesterol per gram of yolk. Significant differences in cholesterol concentrations also were found between domestic and wild genetic groups for turkeys and ducks. In a second study, eggs from 7 inbred lines of chickens showed significant differences in yolk cholesterol. The same general result was found in an analysis of eggs from 17 commercial test strains of chickens at two different ages. Yolk cholesterol tended to decrease as age of hen increased. These results confirm the possibility of genetically selecting for decreased yolk cholesterol if economic or other conditions warrant. The increased efforts required to decrease yolk cholesterol by this approach would undoubtedly be expensive.

The effect of dietary monoterpenes on the cholesterol level of eggs

Monoterpenes were included in the diets of laying hens in an attempt to inhibit the synthesis of cholesterol and hence reduce its amount in egg yolk. However, feeding five monoterpenes, phorone or 200 mg. cholesterol per day to hens did not significantly change the level of cholesterol in the egg yolk. These compounds did not cause signs of ill health in the hen or a decline in egg production.